Webdisclosure.com

Search

INNATE PHARMA (EPA:IPH) French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment in Sézary syndrome and mycosis fungoides

Directive transparence : information réglementée

13/01/2020 23:00